SCN9A and paroxysmal extreme pain disorder: Gain-of-function mutations in Nav1.7 may lead to paresthesia or painful conditions, such as itch, inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD) [95–97].